Purchase Order 75N93025P00260
Award Date 1/21/25
Potential Completion Date 1/16/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded to Bioreliance Corporation, a foreign-owned, for-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $6,065,128.00, is a definitive contract with a cost-plus-fixed-fee pricing type. Bioreliance, through its Life Sciences Services Division, will provide a range of specialized testing services to support investigational new drug...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $15,434.00 firm-fixed-price purchase order to Bioreliance Corporation, a foreign-owned for-profit organization, for endotoxin and sterility testing services. The contract has an ultimate completion date of September 8, 2025. Bioreliance, through its Life Sciences Services division, provides specialized microbiological examination, bioburden...
- This federal contract award, with ID HHSN272201600262P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioreliance Corporation, a foreign-owned, for-profit organization that specializes in providing critical testing services to the U.S. government. The $9,566.00 fixed-price contract is for endotoxin testing services, which are crucial for advancing health initiatives and drug development processes. Bioreliance, through its Life Sciences Services Division,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,561.00 firm fixed price purchase order contract to Bioreliance Corporation, a foreign-owned for-profit company, to provide endotoxin, sterility, and general safety testing services in support of investigational new drug applications. The contract includes isolator sterility testing using direct inoculation methods, LAL testing for...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order to Bioreliance Corporation's Life Sciences Services Division, doing business as Bioreliance Corp De, for $15,434.00 in endotoxin and sterility testing services. The contract, which has a completion date of June 12, 2024, is to provide isolator sterility testing, Limulus Amebocyte Lysate (LAL) testing for...
- This federal contract award is to Bioreliance Corporation, a foreign-owned, for-profit organization, for the provision of specialized testing services to the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The $4,827.00 firm-fixed-price contract is for Bioreliance's Life Sciences Services Division to perform endotoxin, sterility, and general safety testing in support of investigational new drug applications. Bioreliance has extensive...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Bioreliance Corporation, a foreign-owned for-profit organization. The $88,338.85 firm fixed-price delivery order contract is for sterility testing services, including endotoxin, general safety, and microbiological examination testing to support investigational new drug applications. Bioreliance has a long history of providing these services to...
- Bioreliance Corporation, a foreign-owned for-profit organization, was awarded a $34,978 firm-fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) to provide endotoxin, sterility, and general safety testing services in support of investigational new drug (IND) applications for NIAID's Pfs230D1-CRM197 and Pfs230D1-EPA malaria vaccine products. The contract, which does not have a set-aside designation, runs through August 31, 2024. Bioreliance has...
- This federal contract award is for a Definitive Contract with a Ceiling Value of $410,000.00. The contract was awarded to Bioreliance Corporation, a foreign-owned, for-profit organization that provides specialized testing services to the U.S. government, particularly the Department of Health and Human Services. The contract is for "BIOMEDICAL (BASIC)" services, which primarily include endotoxin, sterility, and general safety testing in support of investigational new drug...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services (HHS), to Bioreliance Corporation, a foreign-owned, for-profit organization specializing in critical testing services for the pharmaceutical and biotechnology industries. The $4,930.00 firm fixed-price purchase order is for Bioreliance's cell bank storage and other related functions. This award is not designated as a...